Safety alert issued for injectable drugs as incidents with obesity treatments surge

South Korea's consumer safety authorities have issued a warning about injectable medications after reports of injuries and side effects increased sharply, especially those related to weight loss drugs.
From January 2023 to April 2026, the Korea Consumer Agency received 1,147 reports involving injectable medicines. Flu vaccines accounted for the largest number of reports, while obesity medications ranked second. Reports nearly doubled in 2025 and have continued to rise this year.
The biggest increase involved obesity drugs. Reports rose from only 6 cases in 2024 to 116 cases in 2025, and another 85 cases were reported by April 2026. Common side effects included abdominal pain, vomiting, dizziness, nausea, and tinnitus.
People aged 19 to 49 reported the highest number of problems with obesity drugs. Most incidents happened at home because these medications are usually self-injected, unlike vaccines, which are given by healthcare professionals in clinics or hospitals.
The Korea Consumer Agency advised consumers to carefully follow instructions for storing, using, and injecting these medicines. It also reminded users to follow the correct dosage and treatment period to reduce the risk of side effects.
Edited using generative AI tools.
Source : https://www.koreajoongangdaily.com/business/safety-alert-issued-for-injectable-drugs-as-incidents-with-obesity-treatments-surge/12752391 |